Epigenica Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $2.2M

  • Investors
  • 9

Epigenica General Information

Description

Developer of epigenetic analysis kits intended for comprehensive genome-wide profiling and screening in life sciences research. The company's platform enables researchers to perform comprehensive epigenetic studies at unprecedented speed, scalability, and affordability, offering comprehensive high-throughput profiling at different depths of detail with an array of possible starting materials, enabling researchers to advance biomedical research, drug discovery and development, precision medicine, diagnostics, and therapeutics for aging and longevity.

Contact Information

Website
www.epigenica.se
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Nanna Svartz väg 2
  • 171 65 Solna
  • Sweden
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Devices and Supplies
Vertical(s)
Life Sciences
Corporate Office
  • Nanna Svartz väg 2
  • 171 65 Solna
  • Sweden

Epigenica Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Epigenica Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 30-Jun-2025 $2.2M Completed Generating Revenue
4. Accelerator/Incubator 24-Apr-2025 Completed Generating Revenue
3. Accelerator/Incubator 08-Nov-2023 Completed Generating Revenue
2. Seed Round 16-Oct-2023 $551K $551K Completed Generating Revenue
1. Accelerator/Incubator 17-May-2022 Completed Generating Revenue
To view Epigenica’s complete valuation and funding history, request access »

Epigenica Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
To view Epigenica’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Epigenica Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Epigenica Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Leksell Social Ventures Impact Investing Minority
Navigare Ventures Venture Capital Minority
Voima Ventures Venture Capital Minority
Swedish-American Chamber of Commerce - New York Accelerator/Incubator
EIT Health Accelerator/Incubator Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

Epigenica FAQs

  • When was Epigenica founded?

    Epigenica was founded in 2020.

  • Where is Epigenica headquartered?

    Epigenica is headquartered in Solna, Sweden.

  • What is the size of Epigenica?

    Epigenica has 20 total employees.

  • What industry is Epigenica in?

    Epigenica’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Epigenica a private or public company?

    Epigenica is a Private company.

  • What is Epigenica’s current revenue?

    The current revenue for Epigenica is .

  • How much funding has Epigenica raised over time?

    Epigenica has raised $2.75M.

  • Who are Epigenica’s investors?

    Leksell Social Ventures, Navigare Ventures, Voima Ventures, Swedish-American Chamber of Commerce - New York, and EIT Health are 5 of 9 investors who have invested in Epigenica.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process